1481306

Oxaliplatin für die Systemeignung

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): [SP-4-2-(1R-trans)]-Dichloro(1,2-cyclohexanediamin-N,N′)-platin, [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N′)dichloridoplatinum(II)
• Empirische Formel (Hill-System): C₆H₁₄Cl₂N₂Pt
• CAS-Nummer: 61848-66-6
• Molekulargewicht: 380.17
• MDL number: MFCD00799645
• UNSPSC Code: 41116107
• NACRES: NA.24

Eigenschaften

• grade: pharmaceutical primary standard
• agency: USP
• API family: oxaliplatin
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• storage temp.: 2-8°C
• SMILES string: [Pt+2](Cl)Cl.[N-H]C1C(CCCC1)[N-H]
• InChI: 1S/C6H12N2.2ClH.Pt/c7-5-3-1-2-4-6(5)8;;;/h5-8H,1-4H2;2*1H;/q-2;;;+4/p-2
• InChI key: UUERTZXRKZEANK-UHFFFAOYSA-L

Beschreibung

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Sicherheitshinweise

• pictograms: GHS08,GHS07
• signalword: Danger
• hcodes: H319,H340,H351,H360D,H372
• pcodes: P202 - P260 - P264 - P280 - P305 + P351 + P338 - P308 + P313
• Hazard Classifications: Carc. 2 - Eye Irrit. 2 - Muta. 1B - Repr. 1B - STOT RE 1
• target_organs: Nervous system
• Lagerklasse: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable